Immunoclin (Immunoclin) Research & Development : $0.03 Mil (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Immunoclin's Research & Development for the three months ended in Oct. 2014 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2014 was $0.03 Mil.

Immunoclin Research & Development Historical Data

The historical data trend for Immunoclin's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Research & Development Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Research & Development

0.09

0.10

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Research & Development	Get a 7-Day Free Trial									-	-	0.01	0.02	-

Immunoclin Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

Immunoclin (GREY:IMCL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Immunoclin Research & Development Related Terms

Thank you for viewing the detailed overview of Immunoclin's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines